BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He YF, Zhang MY, Wu X, Sun XJ, Xu T, He QZ, Di W. High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time. PLoS One 2013;8:e79769. [PMID: 24324582 DOI: 10.1371/journal.pone.0079769] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang S, You L, Dai M, Zhao Y. Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis. Ann Transl Med. 2021;9:192. [PMID: 33708819 DOI: 10.21037/atm-20-5606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 He Y, Zhu Q, Chen M, Huang Q, Wang W, Li Q, Huang Y, Di W. The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. Oncotarget 2016;7:70803-21. [PMID: 27683123 DOI: 10.18632/oncotarget.12223] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
3 Dastmalchi N, Khojasteh SMB, Nargesi MM, Safaralizadeh R. The correlation between lncRNAs and Helicobacter pylori in gastric cancer. Pathog Dis 2019;77:ftaa004. [PMID: 31981356 DOI: 10.1093/femspd/ftaa004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xu M, Wang X, Li Y, Geng X, Jia X, Zhang L, Yang H. Arachidonic Acid Metabolism Controls Macrophage Alternative Activation Through Regulating Oxidative Phosphorylation in PPARγ Dependent Manner. Front Immunol 2021;12:618501. [PMID: 34149684 DOI: 10.3389/fimmu.2021.618501] [Reference Citation Analysis]
5 Rodriguez GM, Galpin KJC, McCloskey CW, Vanderhyden BC. The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy. Cancers (Basel) 2018;10:E242. [PMID: 30042343 DOI: 10.3390/cancers10080242] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
6 Li C, Zuo D, Yin L, Lin Y, Li C, Liu T, Wang L. Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2018;2018:6986870. [PMID: 29967641 DOI: 10.1155/2018/6986870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
7 Wu Y, Gao Y, Chen L, Jin X, Chen P, Mo Q. Prognostic implications of tumour-infiltrating lymphocytes for recurrence in epithelial ovarian cancer. Clin Exp Immunol 2021. [PMID: 34195995 DOI: 10.1111/cei.13639] [Reference Citation Analysis]
8 Ngambenjawong C, Pun SH. Multivalent polymers displaying M2 macrophage-targeting peptides improve target binding avidity and serum stability. ACS Biomater Sci Eng 2017;3:2050-3. [PMID: 29430522 DOI: 10.1021/acsbiomaterials.7b00332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
9 Smith PG, Roque D, Ching MM, Fulton A, Rao G, Reader JC. The Role of Eicosanoids in Gynecological Malignancies. Front Pharmacol 2020;11:1233. [PMID: 32982722 DOI: 10.3389/fphar.2020.01233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fucikova J, Coosemans A, Orsulic S, Cibula D, Vergote I, Galluzzi L, Spisek R. Immunological configuration of ovarian carcinoma: features and impact on disease outcome. J Immunother Cancer 2021;9:e002873. [PMID: 34645669 DOI: 10.1136/jitc-2021-002873] [Reference Citation Analysis]
11 Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, Hasanzadeh M, Pasdar A. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles. Cell Oncol (Dordr) 2020;43:515-38. [PMID: 32418122 DOI: 10.1007/s13402-020-00513-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
12 Chen CH, Shyu MK, Wang SW, Chou CH, Huang MJ, Lin TC, Chen ST, Lin HH, Huang MC. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway. Gynecol Oncol 2016;140:131-7. [PMID: 26616226 DOI: 10.1016/j.ygyno.2015.11.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
13 De Nola R, Menga A, Castegna A, Loizzi V, Ranieri G, Cicinelli E, Cormio G. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication. Int J Mol Sci 2019;20:E2401. [PMID: 31096567 DOI: 10.3390/ijms20102401] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
14 Zhou X, Chen H, Zhu L, Hao B, Zhang W, Hua J, Gu H, Jin W, Zhang G. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c. Oncotarget 2016;7:82770-82. [PMID: 27835575 DOI: 10.18632/oncotarget.13165] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
15 Li Y, Xie Z, Wang Y, Hu H. Macrophage M1/M2 polarization in patients with pregnancy-induced hypertension. Can J Physiol Pharmacol 2018;96:922-8. [DOI: 10.1139/cjpp-2017-0694] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
16 Salas-Benito D, Vercher E, Conde E, Glez-Vaz J, Tamayo I, Hervas-Stubbs S. Inflammation and immunity in ovarian cancer. EJC Suppl 2020;15:56-66. [PMID: 33240443 DOI: 10.1016/j.ejcsup.2019.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Li C, Zuo D, Liu T, Yin L, Li C, Wang L. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2019;2019:2391670. [PMID: 31933627 DOI: 10.1155/2019/2391670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chou CL, Chen TJ, Tian YF, Chan TC, Yeh CF, Li WS, Tsai HH, Li CF, Lai HY. Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRT. J Clin Med 2021;10:3030. [PMID: 34300195 DOI: 10.3390/jcm10143030] [Reference Citation Analysis]
19 Martinez A, Delord JP, Ayyoub M, Devaud C. Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer. Cancers (Basel) 2020;12:E1761. [PMID: 32630708 DOI: 10.3390/cancers12071761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gundamaraju R, Vemuri R, Chong WC, Myers S, Norouzi S, Shastri MD, Eri R. Interplay between Endoplasmic Reticular Stress and Survivin in Colonic Epithelial Cells. Cells 2018;7:E171. [PMID: 30326660 DOI: 10.3390/cells7100171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
21 Hu W, Li X, Zhang C, Yang Y, Jiang J, Wu C. Tumor-associated macrophages in cancers. Clin Transl Oncol 2016;18:251-8. [PMID: 26264497 DOI: 10.1007/s12094-015-1373-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
22 Yousefzadeh Y, Hallaj S, Baghi Moornani M, Asghary A, Azizi G, Hojjat-Farsangi M, Ghalamfarsa G, Jadidi-Niaragh F. Tumor associated macrophages in the molecular pathogenesis of ovarian cancer. Int Immunopharmacol 2020;84:106471. [PMID: 32305830 DOI: 10.1016/j.intimp.2020.106471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Owen RP, White MJ, Severson DT, Braden B, Bailey A, Goldin R, Wang LM, Ruiz-Puig C, Maynard ND, Green A, Piazza P, Buck D, Middleton MR, Ponting CP, Schuster-Böckler B, Lu X. Single cell RNA-seq reveals profound transcriptional similarity between Barrett's oesophagus and oesophageal submucosal glands. Nat Commun 2018;9:4261. [PMID: 30323168 DOI: 10.1038/s41467-018-06796-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
24 Cai DL, Jin LP. Immune Cell Population in Ovarian Tumor Microenvironment. J Cancer 2017;8:2915-23. [PMID: 28928882 DOI: 10.7150/jca.20314] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
25 Larionova I, Tuguzbaeva G, Ponomaryova A, Stakheyeva M, Cherdyntseva N, Pavlov V, Choinzonov E, Kzhyshkowska J. Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers. Front Oncol 2020;10:566511. [PMID: 33194645 DOI: 10.3389/fonc.2020.566511] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
26 Xie T, Musteanu M, Lopez-Casas PP, Shields DJ, Olson P, Rejto PA, Hidalgo M. Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression. PLoS One 2015;10:e0142631. [PMID: 26555578 DOI: 10.1371/journal.pone.0142631] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
27 Astashchanka A, Shroka TM, Jacobsen BM. Mucin 2 (MUC2) modulates the aggressiveness of breast cancer. Breast Cancer Res Treat 2019;173:289-99. [PMID: 30317423 DOI: 10.1007/s10549-018-4989-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
28 Barnard ME, Hecht JL, Rice MS, Gupta M, Harris HR, Eliassen AH, Rosner BA, Terry KL, Tworoger SS. Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages. Cancer Epidemiol Biomarkers Prev 2018;27:1509-17. [PMID: 30377203 DOI: 10.1158/1055-9965.EPI-18-0346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yamada Y, Uchiyama T, Ito F, Kawahara N, Ogawa K, Obayashi C, Kobayashi H. Clinical significance of M2 macrophages expressing heme oxygenase-1 in malignant transformation of ovarian endometrioma. Pathol Res Pract 2019;215:639-43. [PMID: 30567635 DOI: 10.1016/j.prp.2018.12.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
30 Frieboes HB, Raghavan S, Godin B. Modeling of Nanotherapy Response as a Function of the Tumor Microenvironment: Focus on Liver Metastasis. Front Bioeng Biotechnol 2020;8:1011. [PMID: 32974325 DOI: 10.3389/fbioe.2020.01011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Caughron B, Yang Y, Young MRI. Role of IL-23 signaling in the progression of premalignant oral lesions to cancer. PLoS One 2018;13:e0196034. [PMID: 29664967 DOI: 10.1371/journal.pone.0196034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
32 Eftimie R. Investigation into the role of macrophages heterogeneity on solid tumour aggregations. Mathematical Biosciences 2020;322:108325. [DOI: 10.1016/j.mbs.2020.108325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Cho U, Kim B, Kim S, Han Y, Song YS. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation. Mol Carcinog 2018;57:235-42. [DOI: 10.1002/mc.22750] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
34 Colvin EK. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol 2014;4:137. [PMID: 24936477 DOI: 10.3389/fonc.2014.00137] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 11.4] [Reference Citation Analysis]
35 Okła K, Wertel I, Polak G, Surówka J, Wawruszak A, Kotarski J. Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges. Int Rev Immunol 2016;35:372-85. [PMID: 27644763 DOI: 10.1080/08830185.2016.1206097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
36 Yao Y, Zhang T, Qi L, Liu R, Liu G, Wang J, Song Q, Sun C. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Biosci Rep 2020;40:BSR20191554. [PMID: 31950990 DOI: 10.1042/BSR20191554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
37 Chou CL, Chen TJ, Tian YF, Chan TC, Yeh CF, Li WS, Tsai HH, Li CF, Lai HY. CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT. Life (Basel) 2021;11:646. [PMID: 34357018 DOI: 10.3390/life11070646] [Reference Citation Analysis]
38 Zhukova OV, Kovaleva TF, Arkhipova EV, Ryabov SA, Mukhina IV. Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review). Biomed Rep 2020;13:47. [PMID: 32934819 DOI: 10.3892/br.2020.1354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W, Ma X. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Gynecol Oncol 2017;147:181-7. [PMID: 28698008 DOI: 10.1016/j.ygyno.2017.07.007] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 16.8] [Reference Citation Analysis]
40 Zhou X, Chen H, Zhu L, Hao B, Zhang W, Hua J, Gu H, Jin W, Zhang G. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c. Oncotarget. 2016;7:82770-82782. [PMID: 27835575 DOI: 10.18632/oncotarget.1316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Jóźwik M, Okungbowa OE, Lipska A, Jóźwik M, Smoktunowicz M, Semczuk A, Jóźwik M, Radziwon P. Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies. BMC Cancer 2015;15:129. [PMID: 25880896 DOI: 10.1186/s12885-015-1136-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]